Video

Clinical Scenario 2: A 66-Year-Old Woman with Locally Advanced Basal Cell Carcinoma

Author(s):

Jennifer L. Atlas, MD,Shahab Babakoohi, MD

Jennifer Atlas, MD, presents the case of a 66-year-old woman with locally advanced basal cell carcinoma not responding to frontline treatment.

Related Videos
Nosha Farhadfar, MD, and Chandler Park, MD, FACP
Eunice Wang, MD, and Chandler Park, MD, FACP
Muhamed Baljevic, MD, FACP and Jorge Cortes, MD, discuss upcoming studies and emerging data being presented at the 2024 ASH Annual Meeting.
Minoo Battiwalla, MD, MS
Farrukh Awan, MD, discusses treatment considerations with the use of pirtobrutinib in previously treated patients with hematologic malignancies.
Francine Foss, MD
David C. Fisher, MD
Farrukh Awan, MD
Minoo Battiwalla, MD, MS
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the role of genomic profiling in secondary acute myeloid leukemia.
Related Content
Zanubrutinib in Newly Diagnosed CLL/SLL | Image Credit: © Свет Лана – stock.adobe.com
December 9th 2024

Zanubrutinib Reduces Long-Term Risk of Progression or Death by 71% in Newly Diagnosed CLL/SLL

Paul J. Shaughnessy, MD, medical director, Adult Blood and Marrow Stem Cell Transplant Program, Methodist Hospital
November 28th 2024

FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL

Chronic Lymphocytic Leukemia | Image Credit: © LASZLO– stock.adobe.com
December 9th 2024

Uproleselan Plus Chemo Fails to Produce OS Benefit in Relapsed/Refractory AML

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

DLBCL | Image credit: ©Nittaya– stock.adobe.com
December 9th 2024

Zilovertamab Vedotin Plus R-CHP Yields 97.2% Overall CR Rate in DLBCL

LBCL | © stock.adobe.com
December 8th 2024

Liso-Cel Shows Broad Spectrum Activity in CIBMTR Cohort of Relapsed/Refractory LBCL